Try our Advanced Search for more refined results
June 03, 2015
Nalpropion Pharmaceuticals, Inc. v. Actavis Laboratories FL, Inc..
Case Number:
1:15-cv-00451
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 13, 2017
Actavis Generic Infringed Weight Loss Pill Patent, Judge Says
A Delaware federal court ruled Friday that generic drug company Actavis Laboratories FL Inc. failed to invalidate patents held by Orexigen Therapeutics Inc. and thus infringed its weight-loss drug Contrave.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login